Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Investigative Ophthalmology & Visual Science|February 12, 2008
Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degenerationRebecca J Ormsby, Shoba Ranganathan, Joo Chuan Tong, et al.
Environmental Research|April 3, 2023
Effects of landscape modification on coastal sediment nitrogen availability, microbial functional gene abundances and N<sub>2</sub>O production potential across the tropical-subtropical gradientPing Yang, Kam W Tang, Linhai Zhang, et al.
The International Journal of Lower Extremity Wounds|March 22, 2015
Effects of the Four-Herb Compound ANBP on Wound Healing Promotion in Diabetic MiceQian Hou, Wen-Jun He, Li Chen, et al.
Journal of Hematology & Oncology|April 5, 2020
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.
Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Signal Transduction and Targeted Therapy|March 18, 2026
DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signalingXinran Ma, Yang Zhang, Yao Wang, et al.
Oncoimmunology|June 15, 2018
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialYao Wang, Meixia Chen, Zhiqiang Wu, et al.
Nature Communications|April 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trialChunmeng Wang, Yelei Guo, Fuxin Han, et al.
Nature Communications|January 19, 2021
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogrammingYao Wang, Chuan Tong, Hanren Dai, et al.
Pageof 22